Trial Profile
Immunogenicity of oral typhoid vaccine CVD-908-htrA and factors influencing response.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Dec 2015
Price :
$35
*
At a glance
- Drugs CVD 908-htrA (Primary)
- Indications Typhoid
- Focus Pharmacodynamics
- 17 Dec 2015 New trial record